CytoSite Biopharma

About:

CytoSite Biopharma is a biotechnology start-up developing a new technology to predict and monitor response to Immuno-Oncology therapy.

Website: http://www.cytositebiopharma.net

Description:

CytoSite Biopharma is a biotechnology start-up developing a new technology to predict and monitor response to Immuno-Oncology therapy. The company develops a novel and proprietary small molecule PET imaging probe that will enable clinicians to predict early in the treatment cycle which patients will respond to I-O therapy. It was founded by James Jenson in 2016 and is based in Sudbury, Massachusetts.

Total Funding Amount:

$7.47M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sudbury, Massachusetts, United States

Founded Date:

2016-01-01

Founders:

James Jenson

Number of Employees:

1-10

Last Funding Date:

2019-09-10

IPO Status:

Private

Industries: